ACI Limited (ACI 20% Convertible Zero Coupon Bonds)
Subscription Open January 31, 2010
Subscription Close February 04, 2010
For Non resident Bangladeshi January 31, 2010 to February 13, 2010
Total Issue Size 1,335,850 Convertible Zero Coupon Bonds of
Tk.1,000 each totaling Tk. 1,335,850,000.
Private Placement 801,510 Convertible Zero Coupon Bonds of Tk.
1,000 each Total Tk. 801,510,000.
Public Offering 534,340 Convertible Zero Coupon Bonds of Tk.
1000 each Total Tk. 534,340,000.
Issue Price (Tk.) 3,743.00
Face Value (Tk.) 5,000.00
Market lot (Share) 5
Public Offer (lots) 106,868
Reason for RPO:
ACI Pharmaceuticals is expected to be introducing
three new lines of medicine products namely Anti
Cancer, Hormone & Steroid and Amino Acid. For
this new initiative, ACI is expected to be invested
Tk. 597 million in new pharmaceuticals projects
and the balance Tk. 403 million is proposed to be
used for working capital and to reduce current
bank borrowings.
Manager to the Issue Alliance Financial Services Limited
Application Document
Available at:
DSE & CSE Library, DSE Members house, Issue
Manager, Underwriter and designated banks.
Website www.aci-bd.com
Major Features of ACI 20% Convertible Zero Coupon Bond
The bond name ACI 20% Convertible Zero Coupon Bond
Issuer ACI Limited
Total Issue Size Issue Value Tk. 1 billion and face value Tk. 1.34 billion
Discount rate 10.5%
Mode of Issue 60% Private placement and 40% Public Offer
Maturity 5 years with yearly redemption
Convertibility 20% of the redemption value can be converted into the
Ordinary shares of ACI Ltd. at each maturity date
Conversion strike price 1.1 times of the net asset value per share as per the
last audited financial statements.
Tradability The Bond will be traded both in DSE and CSE
(If there is any contrary information please communicate with DSE through email:
listing@dsebd.org)
Disclaimer:
The contents of this presentation are entirely based on disclosures made by the
company. Therefore, DSE does not assume any responsibility on the authenticity of
the facts and figures presented thereof.
